Φορτώνει......
Additional antianginal and anti‐ischemic efficacy of mibefradil in patients concomitantly treated with long‐acting nitrates for chronic stable angina pectoris
Background: Mibefradil, a newly approved antihypertensive and antianginal drug, is the first member of a new class of calcium antagonists (CAs), the tetralol derivatives, that selectively blocks T‐type Ca(2+) channels in contrast to classical CAs which, at therapeutic concentrations, block only L‐ty...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Clin Cardiol |
|---|---|
| Κύριοι συγγραφείς: | , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Wiley Periodicals, Inc.
2009
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6656231/ https://ncbi.nlm.nih.gov/pubmed/9669057 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.4960210707 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|